Jennifer Wright Oliver

Title: Innovations in Cancer Treatment by Jennifer Wright Oliver

Introduction

Jennifer Wright Oliver is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods, she has developed a unique approach to addressing genetic alterations associated with cancer.

Latest Patents

Jennifer holds a patent for her groundbreaking work titled "Methods for the treatment of cancer." This patent discloses methods of treating cancer in subjects known to possess at least one genetic alteration in RET. The treatment involves administering a therapeutically effective amount of a specific compound, N-[3-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N'-[5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl]-urea, or a pharmaceutically acceptable salt thereof. This innovative approach has the potential to improve treatment outcomes for patients with specific genetic profiles.

Career Highlights

Jennifer Wright Oliver is associated with Ignyta, Inc., a company dedicated to advancing precision medicine in oncology. Her work at Ignyta has positioned her as a key player in the development of targeted therapies for cancer patients. With her expertise and dedication, she continues to push the boundaries of cancer research and treatment.

Collaborations

Throughout her career, Jennifer has collaborated with talented individuals in the field, including Jonathan Ee-ren Lim and Pratik S Multani. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of cancer treatment methodologies.

Conclusion

Jennifer Wright Oliver's contributions to cancer treatment through her innovative patent and work at Ignyta, Inc. highlight her commitment to improving patient outcomes. Her research and collaborations continue to pave the way for advancements in oncology.